Clinical Cancer Research

A New Era in Patient-Centered Research: Supporting patient-directed clinical trials through the geriatric oncology therapy optimization (GOTO) program August 30, 2022 With the support of Rising Tide Foundation for Clinical Cancer Research (RTFCCR), City of Hope, one of the largest cancer research and treatment organizations in the United States, will launch five coordinated, high-quality research […]

TRIAL UPDATE: First patient enrolled EORTC TOLERANCE July 28, 2022 TRIAL UPDATE: First patient was enrolled in the EORTC TOLERANCE academic clinical trial in elderly patients with advanced soft tissue sarcoma. TOLERANCE is an international study with 9 participating countries. We are proud to support our partner EORTC and would like to say thank you for the good collaboration. You can

New Funding Opportunity: Patient-Centric Clinical Trial Team Science Awards July 19, 2022 The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity RFP for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA. MRA and RTFCCR will jointly support two team awards

Lithuania liberalizes labor migration July 14, 2022 We are excited to celebrate liberalization of labor migration of non-EU nationals passed into law in late June by the Lithuanian parliament. This takes place just under a year after the team at Lithuanian Free Market Institute (LFMI) initiated discussions on systemic reform to address looming demographic and labor market

Scientists discover genes that affect the risk of developing pre-leukaemia July 14, 2022 The discovery of 14 inherited genetic changes which significantly increase the risk of a person developing a symptomless blood disorder associated with the onset of some types of cancer and heart disease is published today in Nature Genetics. The finding, made in

Going the extra mile for people with pancreatic cancer July 12, 2022 BRUSSELS – The Anticancer Fund is partnering with the Rising Tide Foundation for Clinical Cancer Research to support a trial testing a novel strategy in the treatment of patients with pancreatic cancer. As people with pancreatic cancer are currently lacking treatment options, the

RTFCCR grantee update: Impact of DNA mutations on lifelong blood cell production uncovered July 1, 2022 Researchers discover how leukaemia-associated gene mutations steadily commandeer blood cell production over a lifetime, and how these changes relate to ageing and cancer development. New research by scientists at the Wellcome Sanger Institute, the Cambridge Stem Cell Institute, EMBL’s

The Weizmann Institute & Rising Tide Foundation partnership February 4, 2022 Over the years, the Weizmann Institute and Rising Tide Foundation have developed a highly successful partnership supporting a spectrum of translational cancer researchers who are making major contributions to the understanding of cancer and offering new avenues for potential treatment. Our first collaboration spanned

Join us in Celebrating World Cancer Day! February 4, 2022 Due to the great support received we are very proud to confirm that our first virtual art exhibition Patient Arts for Health turns into a continuous virtual art exhibition! We continue to collect and curate patient art offering new insights on what quality of life means. Our goal is to stimulate patients, family